EICHOR ● Not Yet Recruiting

WATER IV PCa (AS Sub-study)

Condition: Localized Prostate Cancer · Sponsor: PROCEPT BioRobotics

PhaseNA

Planned participants333

Who can joinMale, 45 Years to no upper limit

Healthy volunteersNo

About this study

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Angela Lee · 650-232-7215 · a.lee@procept-biorobotics.com

Always discuss trial participation with your own doctor first.

Locations (25)

Arizona Clinical Trials	Chandler, Arizona, United States	—
University of Southern California	Los Angeles, California, United States	—
Tri Valley Urology	Murrieta, California, United States	—
Boulder Medical Center	Boulder, Colorado, United States	—
Advanced Research	Delray Beach, Florida, United States	—
University of Miami	Miami, Florida, United States	—
Georgia Urology	Atlanta, Georgia, United States	—
Mountain View Hospital	Idaho Falls, Idaho, United States	—
University of Chicago	Chicago, Illinois, United States	—
Endeavor Health	Glenview, Illinois, United States	—
Johns Hopkins University	Baltimore, Maryland, United States	—
Kansas City Urology Care	North Kansas City, Missouri, United States	—

+ 13 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →